1. Home
  2. HAFC vs CSTL Comparison

HAFC vs CSTL Comparison

Compare HAFC & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanmi Financial Corporation

HAFC

Hanmi Financial Corporation

HOLD

Current Price

$25.72

Market Cap

770.0M

Sector

Finance

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$25.70

Market Cap

806.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAFC
CSTL
Founded
1982
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
770.0M
806.3M
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
HAFC
CSTL
Price
$25.72
$25.70
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$31.33
$47.17
AVG Volume (30 Days)
212.8K
396.6K
Earning Date
04-21-2026
05-04-2026
Dividend Yield
4.44%
N/A
EPS Growth
22.44
N/A
EPS
2.51
N/A
Revenue
$270,165,000.00
$344,229,000.00
Revenue This Year
$18.65
$2.42
Revenue Next Year
$7.28
$12.69
P/E Ratio
$10.06
N/A
Revenue Growth
15.28
3.66
52 Week Low
$19.25
$14.59
52 Week High
$30.20
$44.28

Technical Indicators

Market Signals
Indicator
HAFC
CSTL
Relative Strength Index (RSI) 44.42 29.22
Support Level $24.44 $24.89
Resistance Level $27.04 $34.97
Average True Range (ATR) 0.71 1.07
MACD 0.01 0.14
Stochastic Oscillator 48.82 18.08

Price Performance

Historical Comparison
HAFC
CSTL

About HAFC Hanmi Financial Corporation

Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: